Announced details
ESG investment, domestic equities, sustainable investment products, environmental, social and governance factors, carbon efficiency, gender diversity
Continued inclusion in the indices since 2017, 2018, 2022, 2023, and 2024, respectively. Selected for inclusion in the FTSE4Good Index Series.
Selected as a constituent of indices adopted by GPIF. FTSE Russell, JPX, S&P Dow Jones Indices, Morningstar, and Equileap are identified as organizations involved in the provision, development, and evaluation of the indices. Capital and personnel relationships: Not disclosed.
GPIF is an independent administrative agency that manages and invests pension reserves. FTSE Russell is a global index provider based in the United Kingdom. Japan Exchange Group (JPX) is involved in the provision and development of indices. Morningstar is a U.S. company, and Equileap is a Dutch company. Other details: Not disclosed.
Sumitomo Pharma headquarters: Osaka City
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Government Pension Investment Fund (GPIF), FTSE Russell, Japan Exchange Group (JPX), MSCI, S&P Dow Jones Indices, Morningstar, Equileap
| Item | Details |
|---|---|
| Names of Products / Services Covered | FTSE JPX Blossom Japan Index, FTSE JPX Blossom Japan Sector Relative Index, MSCI Japan ESG Select Leaders Index, S&P/JPX Carbon Efficient Index, Morningstar Japan ex-REIT Gender Diversity Tilt Index, FTSE4Good Index Series |
| Counterparty | Government Pension Investment Fund (GPIF), FTSE Russell, Japan Exchange Group (JPX), MSCI, S&P Dow Jones Indices, Morningstar, Equileap |
| Counterparty overview | GPIF is an independent administrative agency that manages and invests pension reserves. FTSE Russell is a global index provider based in the United Kingdom. Japan Exchange Group (JPX) is involved in the provision and development of indices. Morningstar is a U.S. company, and Equileap is a Dutch company. Other details: Not disclosed. |
| Relationship with the Company | Selected as a constituent of indices adopted by GPIF. FTSE Russell, JPX, S&P Dow Jones Indices, Morningstar, and Equileap are identified as organizations involved in the provision, development, and evaluation of the indices. Capital and personnel relationships: Not disclosed. |
| Launch date | Track record of continued inclusion in the indices: FTSE JPX Blossom Japan Index since 2017, S&P/JPX Carbon Efficient Index since 2018, FTSE JPX Blossom Japan Sector Relative Index since 2022, Morningstar Japan ex-REIT Gender Diversity Tilt Index since 2023, and MSCI Japan ESG Select Leaders Index since 2024. Date of the current selection: 31 August 2026. |
| Applicable area | ESG investment, domestic equities, sustainable investment products, environmental, social and governance factors, carbon efficiency, gender diversity |
| Location | Sumitomo Pharma headquarters: Osaka City |
| Usage history | Continued inclusion in the indices since 2017, 2018, 2022, 2023, and 2024, respectively. Selected for inclusion in the FTSE4Good Index Series. |
| Source | Government Pension Investment Fund (GPIF), FTSE Russell, Japan Exchange Group (JPX), MSCI, S&P Dow Jones Indices, Morningstar, Equileap |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Sumitomo Pharma Group is promoting sustainability management that contributes to society through value creation based on research and development, thereby leading to sustained growth in corporate value. The indices identify ESG practices, carbon efficiency, environmental information disclosure, and gender diversity, among others, as evaluation criteria and constituent requirements.